Your session is about to expire
← Back to Search
Exercise--Rock Steady Boxing class for Parkinson's Disease (FIGHTPD Trial)
FIGHTPD Trial Summary
This trial is designed to measure the change in patients diagnosed with Parkinson's disease before, during and after a 12 week exercise program, with a focus on the glymphatic system.
- Parkinson's Disease
- Glymphatic System
FIGHTPD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFIGHTPD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FIGHTPD Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the population size of this research endeavor?
"Affirmative, the data on clinicaltrials.gov shows that this research is recruiting patients at present. This experiment was first made public on November 22nd 2019 and its most recent update occurred April 14th 2022. A total of 32 participants need to be recruited from one site for the study's completion."
What are the criteria for enrollment into this research project?
"This clinical trial is accepting 32 individuals afflicted with glial cells aged 55 to 80. Applicants ought to meet the following prerequisites: a diagnosis of Parkinson's disease that meets UK Brain Bank Criteria, responsiveness to levodopa or similar medication, readiness and capacity to join Rock Steady Boxing classes, no consistent aerobic or non-aerobic exercise in previous 6 months, agreeable submission for overnight dopaminergic drug washout period as well as having proper means of attending study visits and boxing sessions."
Is there an age cutoff for enrollment in the trial?
"The minimum age for consideration in this trial is 55 and the maximum is 80. Conversely, there are 30 studies that accept enrollees who are younger than 18 years old and 496 trials which involve adults over 65."
Are there any open enrollment periods for this clinical experiment?
"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial is still recruiting participants since its inception in November 2019 and most recent update in April 2022. The study requires 32 patients from a single site."
Share this study with friends
Copy Link
Messenger